IB
JAZZ icon

Intrust Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Intrust Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,277
Closed -$210K – 383
2021
Q1 		$210K Sell
1,277
-57
-4% -$9.38K 0.03% 363
2020
Q4 		$220K Buy
+1,334
New +$199K 0.03% 331
2020
Q3 		– Sell
-2,083
Closed -$230K – 350
2020
Q2 		$230K Buy
+2,083
New +$230K 0.05% 294
2020
Q1 		– Sell
-1,803
Closed -$269K – 331
2019
Q4 		$269K Sell
1,803
-508
-22% -$69.1K 0.06% 287
2019
Q3 		$296K Buy
2,311
+89
+4% +$11.9K 0.07% 270
2019
Q2 		$317K Sell
2,222
-522
-19% -$70.2K 0.08% 269
2019
Q1 		$393K Buy
2,744
+271
+11% +$35.3K 0.1% 244
2018
Q4 		$306K Buy
2,473
+762
+45% +$113K 0.09% 264
2018
Q3 		$288K Buy
+1,711
New +$294K 0.07% 302

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Intrust Bank's JAZZ Position: Q2 2021 in Review

Intrust Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2021, closing a stake of 1,277 shares — an estimated $210K sold.

Intrust Bank first reported a position in JAZZ in Q3 2018 and held it in 9 quarters. The position peaked at $393K in Q1 2019. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

  • Intrust Bank reported no remaining Jazz Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Intrust Bank sold 1,277 Jazz Pharmaceuticals shares in Q2 2021, an estimated $210K.
  • Intrust Bank first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 9 quarters.
  • Intrust Bank's Jazz Pharmaceuticals position peaked at $393K in Q1 2019.
  • 505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on Intrust Bank's 13F filing for Q2 2021, filed 5 Aug 2021.